PrEP use among pregnant women in Kenya: no adverse effects found
A large PrEP programme for pregnant women in Kenya finds no association between PrEP use and birth complications
A large PrEP programme for pregnant women in Kenya finds no association between PrEP use and birth complications
Sister with a Voice, Zimbabwe’s HIV programme for sex workers, has significantly increased HIV testing, treatment and viral suppression among women who sell sex.
Influential figures and financial compensation particularly effective in increasing voluntary medical male circumcision (VMMC), a new analysis suggests.
HIV incidence more than halved among people from fishing communities in Lake Victoria, Uganda, after rapid expansion of HIV services.
An analysis of gender-based violence (GBV) interventions for young people living with or affected by HIV finds that fewer than half are effective.
Routine point‐of‐care viral load monitoring achieves high testing coverage rates and same-day delivery of results in decentralised clinics.
High HIV prevalence and attrition along the treatment cascade among emergency department (ED) populations highlights potential role of HIV services in theses settings.
To what extent do existing policies relating to age of consent for sexual reproductive health (SRH) services also affect PrEP access?
New technical guidance from the World Health Organization recognises effectiveness of event-driven PrEP for gay men following Prevenir study results.
An Avert spotlight on the HIV response – we reflect on the most important take-homes from the UNAIDS 2019 Global Report.
Multiple complementary interventions scaled up at the national level in Zimbabwe results in improved sexual reproductive health outcomes for young people.
New study finds that questionnaire can improve self-report measures of adherence in children at low-cost.
New study highlights unmet HIV prevention and treatment needs of young key affected populations in Cameroon.
People between the ages of 18-30 who inject drugs in India, are a critical sub-population driving the HIV epidemic in the country.
Compared to the only other approved device for TB detection in people living with HIV, the new FujiLAM point-of-care test offers superior diagnostic sensitivity.
Differentiated care models need further investigation to support people living with HIV with taking their antiretroviral treatment (ART).